{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:29:32Z","timestamp":1791584972787,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejca.2024.115198","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T18:35:22Z","timestamp":1734719722000},"page":"115198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Addressing the role of surgery in brain tumour trials: A report from the neurosurgery committee of the EORTC brain tumour group"],"prefix":"10.1016","volume":"216","author":[{"given":"Johnny","family":"Duerinck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Karschnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marike","family":"Broekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Gempt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.D.","family":"Petrescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asgeir S.","family":"Jakola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Goldbrunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Jenkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Widhalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Neidert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiebaud","family":"Picart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Quoilin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Gorlia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Le Rhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Minniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2024.115198_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejca.2024.115198_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2024.115198_bib3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","article-title":"The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers","volume":"157","author":"Dyba","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2024.115198_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/neuonc\/nox166","article-title":"EANO guidelines for the diagnosis and treatment of ependymal tumors","volume":"20","author":"Rud\u00e0","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/neuonc\/noz153","article-title":"EANO guideline on the diagnosis and treatment of vestibular schwannoma","volume":"22","author":"Goldbrunner","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/neuonc\/noac196","article-title":"European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)","volume":"25","author":"Hoang-Xuan","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib7","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","author":"Weller","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib8","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","article-title":"EANO guideline on the diagnosis and management of meningiomas","volume":"23","author":"Goldbrunner","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(21)00090-5","article-title":"Adjuvant and concurrent temozolomide for 1p\/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study","author":"van den Bent","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib11","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S1470-2045(14)70379-1","article-title":"Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial","volume":"15","author":"Stupp","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/neuonc\/noac173","article-title":"Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial","volume":"25","author":"Lassman","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noae053","article-title":"Marizomib for patients with newly diagnosed glioblastoma: a randomized phase 3 trial","author":"Roth","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib14","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(96)90137-3","article-title":"Surgical research or comic opera: questions, but few answers","volume":"347","author":"Horton","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2024.115198_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znad412","article-title":"From opera buffa to opera seria: anniversaries of Royal College of Surgeons of England research initiatives","volume":"111","author":"Hutchinson","year":"2024","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2024.115198_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","article-title":"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial","volume":"7","author":"Stummer","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib17","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.01862","article-title":"Intraoperative MRI-guided resection is not superior to 5-aminolevulinic acid guidance in newly diagnosed glioblastoma: a prospective controlled multicenter clinical trial","author":"Roder","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib18","unstructured":"Jakola A. Supramarginal Resection in Glioblastoma - NCT04243005. Clinicaltrials.gov n.d. https:\/\/clinicaltrials.gov\/study\/NCT04243005."},{"key":"10.1016\/j.ejca.2024.115198_bib19","unstructured":"Schucht P. Resurge trial - NCTNCT02394626. Clinicaltrials.gov n.d. https:\/\/clinicaltrials.gov\/study\/NCT02394626 (accessed November 14, 2024)."},{"key":"10.1016\/j.ejca.2024.115198_bib20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3171\/2023.7.JNS231170","article-title":"Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): a French multicenter randomized phase III study","volume":"140","author":"Picart","year":"2024","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2024.115198_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113528","article-title":"Effect of high-field iMRI guided resection in cerebral glioma surgery: A randomized clinical trial","volume":"199","author":"Li","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2024.115198_bib22","doi-asserted-by":"crossref","unstructured":"Karschnia P., Young J.S., Dono A., Levin H.\u00e4ni, Sciortino T., Bruno F., et al. Prognostic validation of a new classification system for extent of resection in glioblastoma: a report of the RANO resect group 2022. https:\/\/doi.org\/10.1093\/neuonc\/noac193\/6664041.","DOI":"10.1200\/JCO.2022.40.16_suppl.2003"},{"key":"10.1016\/j.ejca.2024.115198_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061772","article-title":"A systematic review and meta-analysis of supramarginal resection versus gross total resection in glioblastoma: can we enhance progression-free survival time and preserve postoperative safety?","volume":"15","author":"Wach","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2024.115198_bib24","unstructured":"Supratotal Resection for Gliomas Within Noneloquent Areas - NCT02676687. Clinicaltrials.gov n.d. https:\/\/clinicaltrials.gov\/study\/NCT02676687 (accessed August 22, 2024)."},{"key":"10.1016\/j.ejca.2024.115198_bib25","doi-asserted-by":"crossref","unstructured":"Mansouri A., Lai C., Scales D., Pirouzmand F. A phase II pilot randomized controlled trial to assess the feasibility of the \u201csupra-marginal\u201d surgical resection of malignant glioma (G-SUMIT: Glioma supra marginal incision trial) study protocol. Pilot and Feasibility Studies n.d. https:\/\/doi.org\/10.1186\/s40814-022-01104-1.","DOI":"10.1186\/s40814-022-01104-1"},{"key":"10.1016\/j.ejca.2024.115198_bib26","unstructured":"ENCRAM consortium study overview. ENCRAM 2024. https:\/\/encramconsortium.com\/ps\/ (accessed November 14, 2024)."},{"key":"10.1016\/j.ejca.2024.115198_bib27","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3171\/2022.8.JNS221068","article-title":"Surgery for glioblastomas in the elderly: an Association des Neuro-oncologues d\u2019Expression Fran\u00e7aise (ANOCEF) trial","volume":"138","author":"Laigle-Donadey","year":"2023","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2024.115198_bib28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00701-019-03849-w","article-title":"Randomized controlled trials comparing surgery to non-operative management in neurosurgery: a systematic review","volume":"161","author":"Martin","year":"2019","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.ejca.2024.115198_bib29","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(09)61678-0","article-title":"Surgical research: the reality and the IDEAL","volume":"374","author":"The Lancet","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2024.115198_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noae005","article-title":"Leveraging external control data in the design and analysis of neuro-oncology trials: pearls and perils","author":"Polley","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/WCO.0000000000001210","article-title":"Novel trial designs in neuro-oncology","volume":"36","author":"Song","year":"2023","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ejca.2024.115198_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/neuros\/nyaa568","article-title":"Letter: The European and North American Consortium and Registry for Intraoperative Stimulation Mapping: Framework for a Transatlantic Collaborative Research Initiative","volume":"88","author":"Gerritsen","year":"2021","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejca.2024.115198_bib33","doi-asserted-by":"crossref","first-page":"e456","DOI":"10.1016\/S1470-2045(21)00488-5","article-title":"Leveraging external data in the design and analysis of clinical trials in neuro-oncology","volume":"22","author":"Rahman","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2024.115198_bib34","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/neuonc\/noac255","article-title":"Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroups","volume":"25","author":"Gerritsen","year":"2023","journal-title":"Neuro Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924018057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924018057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T01:16:20Z","timestamp":1738199780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804924018057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":34,"alternative-id":["S0959804924018057"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2024.115198","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addressing the role of surgery in brain tumour trials: A report from the neurosurgery committee of the EORTC brain tumour group","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2024.115198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115198"}}